Search results
Results from the WOW.Com Content Network
In a study released on February 2, 2018, scientists from the Icahn School of Medicine at Mount Sinai, led by Dr. Giulio Maria Pasinetti, described an extensive analysis of two novel grape-derived phytochemicals, or natural essential nutrients, dihydrocaffeic acid (DHCA) and malvidin-3’-O-glucoside (Mal-gluc), which might be developed as ...
In 2017, Mount Sinai West entered into settlement concerning the improper disclosure of patient medical records which was settled as the payment of a levied fine of approximately half-a-million dollars as reported in the medical journal Becker Hospital Review stating: "New York City-based St. Luke's-Roosevelt Hospital Center (Mount Sinai West ...
Mount Sinai Hospital, 1519 South California Ave. in 1922. The second Jewish hospital to be established in the city, Mount Sinai Hospital differed from Michael Reese Hospital, which had been established in 1881 on Chicago's South Side primarily by German Jews, whereas Mount Sinai was founded by Eastern European Jews. [3]
Scott L. Friedman (born June 13, 1955) [citation needed] is an American scientist, professor and physician who works in the field of hepatology.Friedman has conducted pioneering research into the underlying causes of scarring, or fibrosis, associated with chronic liver disease, by characterizing the key fibrogenic cell type, the hepatic stellate cell [1] His laboratory has also discovered a ...
Thomas J. Oxley is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. [1] Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. [2]
Kenneth L. Davis is the executive vice chairperson of the board of trustees at the Mount Sinai Health System in New York City, [1] [2] and an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's disease designed specifically to evaluate the severity of cognitive and ...
Brendan G. Carr is an American physician and educator. He is Chief Executive Officer and Kenneth L. Davis, MD, Distinguished Chair of the Mount Sinai Health System as of 2024, [1] and Professor and of Emergency Medicine at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System.
Reidenberg became interested in animal science and art as a high school student. She earned a bachelor's degree (B.A.) from Cornell University in 1983, a master's (M.Phil.) from the Mount Sinai School of Medicine Graduate Program in Biological Sciences in 1985, and a doctorate (Ph.D.) in Biomedical Sciences: Anatomy in 1988.